On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.
Latest News
The Motley Fool’s 2026 AI Survey: Only 7% of AI Investors Plan to Sell
The Motley Fool’s 2026 AI Investor Outlook Report found that 9-in-10 AI investors plan to hold or buy more AI stocks in the next
Ratings comparison between Vanguard S&P 500 ETF and Vanguard Total Stock Market ETF
In the latest Seeking Alpha analysis as of early 2026, the Vanguard S&P 500 ETF (VOO) earns a Quant rating of Buy with a
Best money market account rates today, January 20, 2026 (Earn up to 4.1% APY)
Money market account interest rates today are still well above historical norms. Find out where to get the best money market account rates now.
Microsoft vs Palantir: Which Tech Stock Is A Better Buy Today
Artificial intelligence (AI) has changed the way we look at every industry. Businesses are setting aside millions to invest in AI and remain ahead
Exxon Mobil, Altria, and Other Defensive Dividend Stocks for a Rocky Market
Investors can look to dividend stocks, particularly in energy and consumer staples, to ride out the geopolitical storms.
Why this Treasury-market selloff could spell trouble for stocks
The sharp move higher for the benchmark 10-year Treasury yield on Tuesday could spell trouble for stocks, according to Adam Turnquist, Chief Technical Strategist
Stock market today: Dow, S&P 500, Nasdaq sink as Trump tariff threats and bond sell-off shake Wall Street
US stocks posted hefty losses Tuesday after President Trump reignited trade-war tensions with Europe over Greenland, while a Japan-led global bond sell-off reverberated through
Small caps stand out amid drop in broader market Tuesday, as rotation trade quietly continues
Market leadership isn’t defined by up days alone. Even on a volatile down day like Tuesday, the broader selloff didn’t stop investors’ rotation away
Will Nvidia Break $300 in 2026 or Should You Buy Broadcom Stock Instead?
There has been a loss of momentum for Nvidia (NASDAQ:NVDA) in recent months, which has been the case for many other stocks leading the